sanofi news - Search News

Teva, Sanofi gain

Reuters on MSN · 3d

Teva, Sanofi say bowel disease drug met primary targets (Dec 17)

Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping it will become a blockbuster drug - or one that generates annual sales of at least $1 billion.

MarketWatch · 4d

Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial

Teva Pharmaceuticals and Sanofi report that the latest trial of their jointly developed treatment for inflammatory bowel disease met its primary endpoints. The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group.

Seeking Alpha on MSN · 4d

Teva, Sanofi gain after mid-stage trial win for IBD therapy

ADRs of Teva Pharmaceutical (NYSE:TEVA) and Sanofi (NASDAQ:SNY) traded higher in the premarket on Tuesday after the companies said that their experimental antibody therapy, duvakitug, reached the main goals in a Phase 3 trial for patients with two of the major inflammatory bowel diseases (IBD).

Reuters on MSN · 4d

Teva, Sanofi say drug to treat IBD met primary targets

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and Crohn's disease showed it had met primary goals. Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD),

FierceBiotech1d

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision

As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...

Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program

The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.

1d

Sanofi’s Tolebrutinib Receives FDA Breakthrough Therapy Designation for nrSPMS

Sanofi ( (SNY) ) has issued an announcement.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...

Modern Healthcare4d

Sanofi sues feds over moves to stop 340B rebate proposal

Sanofi, Johnson & Johnson, Eli Lilly and Bristol Myers Squibb have each filed complaints after facing federal opposition to ...

Pharmalittle: We’re reading about Congress reining in PBMs, Sanofi suing HHS, and more

After two years of haggling, Congress has nearly reached a deal to rein in pharmacy benefit managers, STAT reports. Lawmakers ...

FierceBiotech4d

Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial

As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...

Sanofi and Regeneron's Dupixent, Leo Pharma's Anzupgo could help close treatment gap in chronic hand eczema: GlobalData

Sanofi and Regeneron are in the process of testing out blockbuster biologic Dupixent in the indication, for one, and ...

3don MSN

Sanofi employees embrace spirit of giving, fulfilling wishes for families in need

It's a special delivery for Pocono Services for Families and Children at the Mountain Center in Tobyhanna. Bag after bag of ...

1d

Sanofi to acquire rights to develop, commercialize aficamten from Corxel

Cytokinetics (CYTK) announced that Sanofi (SNY) will acquire exclusive rights to develop and commercialize aficamten from Corxel ...

4d

Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug

Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 ...

Rx Rundown: Sanofi, Novartis, Roche and more

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

2d

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Jean-Paul Kress to join Sanofi's Board of DirectorsParis, December 19, 2024. Sanofi's Board of Directors is pleased to welcome Jean-Paul Kress as ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results